Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Common Equity (2016 - 2025)

Sensus Healthcare has reported Common Equity over the past 10 years, most recently at $48.1 million for Q4 2025.

  • Quarterly results put Common Equity at $48.1 million for Q4 2025, down 13.84% from a year ago — trailing twelve months through Dec 2025 was $48.1 million (down 13.84% YoY), and the annual figure for FY2025 was $48.1 million, down 13.84%.
  • Common Equity for Q4 2025 was $48.1 million at Sensus Healthcare, down from $51.2 million in the prior quarter.
  • Over the last five years, Common Equity for SRTS hit a ceiling of $55.8 million in Q4 2024 and a floor of $20.2 million in Q2 2021.
  • Median Common Equity over the past 5 years was $47.6 million (2022), compared with a mean of $43.7 million.
  • Biggest five-year swings in Common Equity: decreased 16.82% in 2021 and later surged 128.68% in 2022.
  • Sensus Healthcare's Common Equity stood at $26.0 million in 2021, then soared by 84.77% to $48.1 million in 2022, then rose by 1.61% to $48.8 million in 2023, then rose by 14.3% to $55.8 million in 2024, then dropped by 13.84% to $48.1 million in 2025.
  • The last three reported values for Common Equity were $48.1 million (Q4 2025), $51.2 million (Q3 2025), and $52.1 million (Q2 2025) per Business Quant data.